Journal of Oncology

Epigenetic Alterations in Tumorigenesis


Publishing date
01 Jan 2023
Status
Closed
Submission deadline
26 Aug 2022

Lead Editor
Guest Editors

1Southern University of Science and Technology, Shenzhen, China

2Clark Atlanta University, Atlanta, USA

3Harvard Medical School, Boston, USA

This issue is now closed for submissions.

Epigenetic Alterations in Tumorigenesis

This issue is now closed for submissions.

Description

Epigenetics is defined as functional and inheritable changes in the regulation of gene activity and expression without altering the primary DNA sequence, which is dynamic and susceptible to environmental exposures. Epigenetic regulation includes DNA methylation and demethylation, as well as posttranslational modifications of histones, chromatin remodeling, nucleosome positioning, and non-coding RNAs. Both epigenetic and genetic alterations contribute to cancer initiation and progression. In the process of tumor formation and development, epigenetic alteration has increasingly attracted attention. Aberrant epigenetic regulation contributes to cancer development through its involvement in tumor growth, apoptosis, senescence, invasion, metastasis, stemness, and drug resistance.

Similar to cancer genetics, cancer epigenetics has advanced due to high-throughput technology to characterize the epigenetic changes at the global and single-molecular levels. Epigenetic alterations may promote genetic mutations and genomic rearrangements in cancer, although the mechanisms involved are yet to be elucidated. A greater understanding of epigenetics and the therapeutic potential of intervention into these processes is necessary to help clinical treatment of cancer. More importantly, there are quite a number of scientific and pragmatic challenges to discovering epigenetic drugs as we are just beginning to understand the complexities of epigenetic events.

The aim of this Special Issue is to collate findings associated with epigenetic factors as ‘drivers’ or regulators of tumorigenesis. We welcome both original research and review articles.

Potential topics include but are not limited to the following:

  • DNA methylation in cancer
  • Histone modification in cancer
  • Non-coding RNA in cancer
  • Epigenetic reprogramming in tumor metastasis
  • Epigenetic alteration in cancer chemoresistance
  • Epigenetic factors as therapeutic targets
  • Epigenetic factors as diagnostic markers
  • The development of compounds that target enzymes involved in regulating the epigenome
  • Epigenetic regulation of cancer stem cell formation and maintenance
  • Epigenetic regulation of tumor microenvironment

Articles

  • Special Issue
  • - Volume 2022
  • - Article ID 8802573
  • - Research Article

Establishing a Novel Gene Signature Related to Histone Modifications for Predicting Prognosis in Lung Adenocarcinoma

Mengfeng Liu | Xiran Yu | ... | Changfa Qu
  • Special Issue
  • - Volume 2022
  • - Article ID 9016296
  • - Research Article

The Interaction of the IFNγ/JAK/STAT1 and JAK/STAT3 Signalling Pathways in EGFR-Mutated Lung Adenocarcinoma Cells

Yaguang Han | Yan Zhang | ... | Aixia Sui
  • Special Issue
  • - Volume 2022
  • - Article ID 9025198
  • - Research Article

Identification of Gene Coexpression Modules and Prognostic Genes Associated with Papillary Thyroid Cancer

Yanbing Shen | Wenfei He | ... | Yilin Hu
  • Special Issue
  • - Volume 2022
  • - Article ID 4419119
  • - Research Article

Constructing a Novel Prognostic Signature Based on TGF-β Signaling for Personalized Treatment in Pancreatic Adenocarcinoma

Tengfei Ji | Hongsheng Wu | Keqiang Ma
  • Special Issue
  • - Volume 2022
  • - Article ID 8570882
  • - Research Article

Identification of Novel Immunologic Checkpoint Gene Prognostic Markers for Ovarian Cancer

Xiao Huo | Xi Zhang | ... | Mo Yang
  • Special Issue
  • - Volume 2022
  • - Article ID 3140263
  • - Research Article

Integrated Machine Learning and Single-Sample Gene Set Enrichment Analysis Identifies a TGF-Beta Signaling Pathway Derived Score in Headneck Squamous Cell Carcinoma

Sheng Wu | Xiangkang Lv | ... | Yong Li
  • Special Issue
  • - Volume 2022
  • - Article ID 7253876
  • - Research Article

The Association between Immune Subgroups and Gene Modules for the Clinical, Cellular, and Molecular Characteristic of Hepatocellular Carcinoma

Wenbiao Chen | Peng Zhu | ... | Changchun Guo
  • Special Issue
  • - Volume 2022
  • - Article ID 7745675
  • - Research Article

Identification of Tumor Microenvironment Scoring Scheme Based on Bioinformatics Analysis of Immune Cell Infiltration Pattern of Ovarian Cancer

Xiao Huo | Mo Yang | ... | Hengzi Sun
  • Special Issue
  • - Volume 2022
  • - Article ID 6851026
  • - Research Article

Identifying Potential Tumor Antigens and Antigens-Related Subtypes in Hepatocellular Carcinoma for mRNA Vaccine Development

Weiran Liao | Zhitian Shi | ... | Lin Wang
  • Special Issue
  • - Volume 2022
  • - Article ID 3588117
  • - Research Article

Novel DNA Damage-Related Subtypes Characterization Identifies Uterine Corpus Endometrial Carcinoma (UCEC) Based on Machine Learning

Qi Yu | Xinqi Ge | ... | Liping Chen
Journal of Oncology
 Journal metrics
See full report
Acceptance rate6%
Submission to final decision136 days
Acceptance to publication68 days
CiteScore3.900
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

Article of the Year Award: Impactful research contributions of 2022, as selected by our Chief Editors. Discover the winning articles.